SURMODICS INC — Director's Dealing 2010

Mar 23, 2010

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2010-03-15

Reporting Person: Middleton John C. (VP, Drug Del, Product Dev)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2274	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (Right to Buy)	$37.51	2015-09-15	Common Stock (5000)		Direct
Employee Stock Option (Right to Buy)	$24.30	2016-09-21	Common Stock (12000)		Direct

Footnotes

F1: Exercisable in annual increments of 25%, commencing 09/15/2009.

F2: Exercisable in annual increments of 25%, commencing 09/21/2010.